<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>T 20 Pharmacology Test 4 (Cvs)   29 06 2023   2023 06 29</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">T 20 Pharmacology Test 4 (Cvs)   29 06 2023   2023 06 29</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 20 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 30 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 20</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">T 20 Pharmacology Test 4 (Cvs)   29 06 2023   2023 06 29 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 20</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 20 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Which of the following drugs acts as an antagonist of nicotinic receptors and is useful as an antidote for nicotine poisoning?", "options": [{"label": "A", "text": "Trimethoprim", "correct": false}, {"label": "B", "text": "Triazolam", "correct": false}, {"label": "C", "text": "Trimethaphan", "correct": true}, {"label": "D", "text": "Triclabendazole", "correct": false}], "correct_answer": "C. Trimethaphan", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C. Trimethaphan</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>‚Ä¢ Explanation of Other Options:</li><li>‚Ä¢ Option A: Trimethoprim</li><li>‚Ä¢ Option A: Trimethoprim</li><li>‚Ä¢ Trimethoprim is an antibiotic that inhibits bacterial dihydrofolate reductase. It has no action on nicotinic receptors and is not used as an antidote for nicotine poisoning.</li><li>‚Ä¢ Option B: Triazolam</li><li>‚Ä¢ Option B: Triazolam</li><li>‚Ä¢ Triazolam is a short-acting benzodiazepine used for the treatment of insomnia. It does not act on nicotinic receptors and is not relevant for treating nicotine poisoning.</li><li>‚Ä¢ Option D: Triclabendazole</li><li>‚Ä¢ Option D: Triclabendazole</li><li>‚Ä¢ Triclabendazole is an antiparasitic drug used to treat infections caused by liver flukes. It does not affect nicotinic receptors and is not used as an antidote for nicotine poisoning.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Trimethaphan is a nicotinic receptor antagonist that can be used as an antidote for nicotine poisoning by blocking the effects of nicotine at autonomic ganglia.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is NOT true about the use of beta blockers in CHF?", "options": [{"label": "A", "text": "These should be started at very low dose and slowly titrated upwards", "correct": false}, {"label": "B", "text": "Carvedilol is most widely used beta blocker", "correct": false}, {"label": "C", "text": "These are drug of choice in acute decompensated heart failure", "correct": true}, {"label": "D", "text": "These can reduce mortality in CHF patients", "correct": false}], "correct_answer": "C. These are drug of choice in acute decompensated heart failure", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C. These are drug of choice in acute decompensated heart failure</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>‚Ä¢ Explanation of Other Options:</li><li>‚Ä¢ Option A: These should be started at very low dose and slowly titrated upwards</li><li>‚Ä¢ Option A: These should be started at very low dose and slowly titrated upwards</li><li>‚Ä¢ Beta blockers should indeed be started at very low doses and slowly titrated upwards. This cautious approach is necessary to avoid acute decompensation and to allow the patient‚Äôs body to adjust to the medication gradually.</li><li>‚Ä¢ Option B: Carvedilol is most widely used beta blocker</li><li>‚Ä¢ Option B: Carvedilol is most widely used beta blocker</li><li>‚Ä¢ Carvedilol is one of the most widely used beta blockers in the management of chronic heart failure due to its non-selective beta-blocking properties and additional alpha-blocking effects, which can provide beneficial vasodilation.</li><li>‚Ä¢ Option D: These can reduce mortality in CHF patients</li><li>‚Ä¢ Option D: These can reduce mortality in CHF patients</li><li>‚Ä¢ Beta blockers have been shown to reduce mortality in patients with chronic heart failure. They help by reducing the heart rate, decreasing myocardial oxygen demand, and preventing the detrimental effects of chronic sympathetic nervous system activation.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Beta blockers are crucial in managing chronic heart failure, started at low doses and titrated slowly to avoid acute decompensation. They are not used in acute decompensated heart failure but can reduce mortality in chronic heart failure patients.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Pure action potential prolonging drug without any other effect on action potential is :", "options": [{"label": "A", "text": "Quinidine", "correct": false}, {"label": "B", "text": "Amiodarone", "correct": false}, {"label": "C", "text": "Ibutilide", "correct": true}, {"label": "D", "text": "Lignocaine", "correct": false}], "correct_answer": "C. Ibutilide", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C. Ibutilide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>‚Ä¢ Explanation of Other Options:</li><li>‚Ä¢ Option A: Quinidine</li><li>‚Ä¢ Option A: Quinidine</li><li>‚Ä¢ Quinidine is a class IA antiarrhythmic drug that not only prolongs the action potential but also has effects on sodium channels, leading to a decrease in the slope of phase 0 (depolarization) of the action potential.</li><li>‚Ä¢ Option B: Amiodarone</li><li>‚Ä¢ Option B: Amiodarone</li><li>‚Ä¢ Amiodarone is a class III antiarrhythmic drug that prolongs the action potential duration but also has multiple effects on sodium, potassium, and calcium channels, as well as adrenergic receptors, making its action more complex and not purely limited to action potential prolongation.</li><li>‚Ä¢ Option D: Lignocaine</li><li>‚Ä¢ Option D: Lignocaine</li><li>‚Ä¢ Lignocaine (also known as Lidocaine) is a class IB antiarrhythmic drug that primarily shortens the action potential duration and has effects on sodium channels, leading to a decrease in the slope of phase 0 (depolarization) of the action potential.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Ibutilide is a pure action potential prolonging drug, primarily affecting potassium channels without other significant effects on the action potential, unlike other antiarrhythmics like amiodarone, lignocaine and quinidine, which have multiple channel effects.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not a first line anti-hypertensive drug?", "options": [{"label": "A", "text": "Enalapril", "correct": false}, {"label": "B", "text": "Telmisartan", "correct": false}, {"label": "C", "text": "Metoprolol", "correct": true}, {"label": "D", "text": "Amlodipine", "correct": false}], "correct_answer": "C. Metoprolol", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C. Metoprolol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>‚Ä¢ Explanation of Other Options:</li><li>‚Ä¢ Option A: Enalapril</li><li>‚Ä¢ Option A: Enalapril</li><li>‚Ä¢ Enalapril is an angiotensin-converting enzyme (ACE) inhibitor. ACE inhibitors are commonly used as first-line agents in the management of hypertension due to their efficacy and benefits in reducing cardiovascular events.</li><li>‚Ä¢ Option B: Telmisartan</li><li>‚Ä¢ Option B: Telmisartan</li><li>‚Ä¢ Telmisartan is an angiotensin II receptor blocker (ARB). ARBs are also considered first-line antihypertensive agents, particularly useful in patients who cannot tolerate ACE inhibitors.</li><li>‚Ä¢ Option D: Amlodipine</li><li>‚Ä¢ Option D: Amlodipine</li><li>‚Ä¢ Amlodipine is a calcium channel blocker (CCB). Calcium channel blockers are first-line antihypertensive agents due to their effectiveness in lowering blood pressure and their favourable safety profile.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Beta-blockers like metoprolol are not considered first-line therapy for hypertension unless there are specific indications such as heart failure or post-myocardial infarction. Diuretics, ACE inhibitors, ARBs, and calcium channel blockers are preferred first-line antihypertensive drugs.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 44-year-old obese man has extremely high plasma triglyceride levels, but cholesterol levels are within normal limits. Following treatment with a drug specifically indicated for hypertriglyceridemia, triglyceride levels decrease to almost normal. Which of the following agents is most likely to have caused this desired change?", "options": [{"label": "A", "text": "Atorvastatin", "correct": false}, {"label": "B", "text": "Cholestyramine", "correct": false}, {"label": "C", "text": "Ezitemibe", "correct": false}, {"label": "D", "text": "Fenofibrate", "correct": true}], "correct_answer": "D. Fenofibrate", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D. Fenofibrate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>‚Ä¢ Explanation of Other Options:</li><li>‚Ä¢ Option A: Atorvastatin</li><li>‚Ä¢ Option A: Atorvastatin</li><li>‚Ä¢ Atorvastatin is an HMG-CoA reductase inhibitor (statin) primarily used to lower LDL cholesterol. While statins can modestly lower triglyceride levels, they are not the first choice for patients with isolated hypertriglyceridemia.</li><li>‚Ä¢ Option B: Cholestyramine</li><li>‚Ä¢ Option B: Cholestyramine</li><li>‚Ä¢ Cholestyramine is a bile acid sequestrant that primarily lowers LDL cholesterol. It is not effective for significantly lowering triglyceride levels and is not indicated for isolated hypertriglyceridemia.</li><li>‚Ä¢ Option C: Ezetimibe</li><li>‚Ä¢ Option C: Ezetimibe</li><li>‚Ä¢ Ezetimibe is a cholesterol absorption inhibitor that primarily lowers LDL cholesterol by inhibiting the absorption of cholesterol in the small intestine. It does not have a significant effect on triglyceride levels.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Fenofibrate is the drug of choice for the treatment of hypertriglyceridemia, effectively reducing plasma triglyceride levels by activating PPAR-Œ± and increasing fatty acid oxidation.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient with angina is started on a nitroglycerin transdermal delivery system (‚Äúskin patch‚Äù) for prophylaxis of his angina. He wears the patch 24 h a day, 7 days a week, except for the few minutes when he showers each day. Which of the following is the main concern with ‚Äúaround-the-clock‚Äù administration of this drug?", "options": [{"label": "A", "text": "Cyanide poisoning", "correct": false}, {"label": "B", "text": "Development of tolerance to their vasodilator actions", "correct": true}, {"label": "C", "text": "Onset of delayed, characteristic adverse responses including thrombosis and thrombocytopenia", "correct": false}, {"label": "D", "text": "Paradoxical vasoconstriction leading to hypertension", "correct": false}], "correct_answer": "B. Development of tolerance to their vasodilator actions", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B. Development of tolerance to their vasodilator actions</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>‚Ä¢ Explanation of Other Options:</li><li>‚Ä¢ Option A: Cyanide poisoning</li><li>‚Ä¢ Option A: Cyanide poisoning</li><li>‚Ä¢ Cyanide poisoning is associated with the use of sodium nitroprusside, not nitroglycerine. Nitroglycerine does not release cyanide as a byproduct.</li><li>‚Ä¢ Option C: Onset of delayed, characteristic adverse responses including thrombosis and thrombocytopenia</li><li>‚Ä¢ Option C: Onset of delayed, characteristic adverse responses including thrombosis and thrombocytopenia</li><li>‚Ä¢ There is no significant association between nitroglycerine use and delayed adverse responses such as thrombosis or thrombocytopenia. These effects are not typical of nitroglycerine therapy.</li><li>‚Ä¢ Option D: Paradoxical vasoconstriction leading to hypertension</li><li>‚Ä¢ Option D: Paradoxical vasoconstriction leading to hypertension</li><li>‚Ä¢ Nitroglycerine does not cause paradoxical vasoconstriction or hypertension. Its primary action is vasodilation, and tolerance development does not lead to paradoxical vasoconstriction.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>‚û§ Educational Objective:</li><li>‚û§ Continuous, around-the-clock administration of nitroglycerine can lead to the development of tolerance, reducing the drug